11 research outputs found

    Aproximación a la fenología de Lixus junci Boheman (Coleoptera: Curculionidae) en La Rioja Alta: estimación de las pérdidas que causa

    No full text

    Ensayos sobre la actividad antialimentaria de un extracto etanólico de hojas de Daphne gnidium L. frente a cuatro especies de insectos

    No full text

    Evaluación de la capacidad inhibidora de la alimentación de un triturado de semillas de chirimoya, "anonna cherimola" Miller (Anonnaceae), sobre "Ceratitis capitata" (Wiedemann) (Diptera: Tephritidae)

    No full text
    The Mediterranean fruit fly, Ceratitis capitata (Wiedemann) (Diptera, Tephritidae), constitutes one of the most important pests on fruit trees in Andalucía (Southern Spain). In the province of Granada coast, a new industry to extract pulp of fruits of Anona cherimola Miller (Anonnaceae) to make several kinds of lacteous preparations is actually developing. Due to this fact, seeds are a subproduct of the cited activity, so bioassays on the addition of different doses of whole triturated seeds to the semiartificial rearing diet of the dipteran were carryed out. Results indicate that the cited product has an antifeedant activity on larvae of the cited pes

    Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review

    No full text
    Crohn’s disease and ulcerative colitis are the two most common categories of inflammatory bowel disease (IBD), which are characterized by chronic inflammation of the intestine that comprises the patients’ life quality and requires sustained pharmacological and surgical treatments. Since their aetiology is not completely understood, nonfully efficient drugs have been developed and those that show effectiveness are not devoid of quite important adverse effects that impair their long-term use. Therefore, many patients try with some botanical drugs, which are safe and efficient after many years of use. However, it is necessary to properly evaluate these therapies to consider a new strategy for human IBD. In this report we have reviewed the main botanical drugs that have been assessed in clinical trials in human IBD and the mechanisms and the active compounds proposed for their beneficial effects
    corecore